Navigation Links
A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at 'Autism Through the Lifespan' Conference February 14-17 in Orlando
Date:2/13/2008

ORLANDO, Fla., Feb. 13 /PRNewswire-USNewswire/ -- Leading speech pathologist and autism consultant Valerie Herskowitz will present her findings on the latest special needs technologies at the "Autism Through the Lifespan" conference to be held Feb 14-17 in Orlando.

"The future is now for an entire generation of children challenged with autism, reaching the adolescent stage of their lives and becoming young adults with autism. Technology is the key to maximizing their future independence. By teaching children with autism how to utilize technology, we are not only arming them with tools to capitalize on their present successes, but setting the stage for the real possibility of future independence," Herskowitz said.

Technological advances designed to equip the special needs home of the future include Herskowitz's research on specialized software programs for use in teaching skills to a special needs population.

"From devices that use robotics to perform housekeeping activities, to a simple mirror that reminds you of your appointments, I envision communities where adults with developmental disabilities can live and work together in a supported environment of homes equipped with state-of-the-art advances for special needs," Herskowitz added.

Herskowitz is President of non-profit the National Autism Registry and serves on the advisory board of US Autism & Asperger Association. The founder of the Dimensions Therapy Center which provides private therapy services and special events around the South Florida area for families with special needs, Herskowitz is expanding her computer-based intervention for families on a national scale by establishing a "global autism support village" through podcasts, webcasts and other cyber tools at http://www.valerieherskowitz.com .

Herskowitz's career as a speech pathologist spans some 30 years. A recipient of the Stevie Lifetime Achievemen
'/>"/>

SOURCE Valerie Herskowitz
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Just in Time for Fall Baking and Entertaining: The Sneaky Chef Tips Featuring Eagle Mills All-Purpose Flour made with Ultragrain(R)
2. Food tricks that combat sneaky, creepy Halloween treats
3. Sneaky Chefs Recipes Make Delicious Debut at Morgan Stanley Childrens Hospital
4. Knowing Your Risks Can Stop the Sneak Thief of Sight
5. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
6. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
7. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
8. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
9. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
10. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
11. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...ong Kong experts concluded that there is a genetic...at SARS is transmitted to human beings through// c...e Information Times newspaper on Thursday. The r...et cats, by the Center for Disease Control and Pro...
... adolescents are enjoying the health and social be...ny observers have noted problems related to// over...le sport medicine physicians have seen alarming in...es. The November/December issue of the Clinical Jo...
...n funds to the tune of SFr25 million ($20 million)... Technology in Lausanne to invest in the creation ... the brain. The joint venture, envisaged for five...er in children. Also research to lessen the impact...
...cials have banned the sale of turbot after they de...//at several of Beijing’s fish markets, reports th... Cao Jilin from Europe in 1992. Due to low resist...medicinal supplements, which sometime leave harmfu...
Other Medicine News:Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3
(Date:10/10/2008)...tment with Kogenate FS Reduces the,Risk of Joint D...Existing,Joint Damage, BERKELEY, Calif., Oct. 10 ...ay that the U.S. Food and Drug Administration (FDA...) FS Antihemophilic Factor,(Recombinant) to reduce...f,joint damage in patients aged 0-16 years with se...
(Date:10/9/2008)...e need to protect the eyesight of,older people, N...people worldwide who,are blind, 80 percent are ove...oided their blindness if they had been properly di...Release, go to:, http://www.prnewswire.com/mnr/orb... products and equipment, is,partnering with nonpro...
(Date:10/8/2008)...e-USNewswire/ -- The facts are,overwhelming. Every...-Saharan Africa. More than 35,000,000 women, child...ed of AIDS. The Foundation for Hospices,in Sub-Sah...ir families,find compassion and relief from suffer...ing initiative links African hospices and palliati...
(Date:10/8/2008)...ts Expand Testing Using Cellular ... Oct. 8 /- Wild Blueberry antioxidant...ts from a new study,showing Wild Blueberries outpe...e apples, bananas, red grapes and strawberries in ...tivity (CAA) assay. New research,published in the ...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 1ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 1909 3Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call 4896 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 1Story of Womans Courage and Medical Innovation Top Choice for Readers 17825 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 1Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 3Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4894 4
...un 7, 2007 - Clinical results from a,Phase II stud...dache Society (AHS) annual meeting showed that MK-...ted peptide (CGRP),receptor antagonist, significan...dosing compared to placebo, and the relief was,sus...l tolerated in,the study. Responses specific to ot...
...ndpoints for Both Efficacy and Safety, LEXINGTON, ...evus Pharmaceuticals, Inc. today announced final r...r NEBIDO (testosterone,undecanoate), a long- actin...t for the treatment of male hypogonadism which the...ermany. The data,from the recently completed 48-we...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
...ed on the competition principle and the microplate...n the sample and a fixed amount of DHEA-S conjugat...nding sites of a polyclonal DHEA-S antiserum coate...crotiterplate is washed to stop the competition re...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum.
Equipped with the SYNCHRON CX4 PRO, which includes many of today's most advanced and automated technologies, your laboratory can improve its specialty testing process dramatically. The SYNCHRON CX4 P
Medicine Products: